ABM Industries, Inc. (ABM)
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
NYSEIndustrialsSpecialty Business ServicesSnapshot 2026-09-04
Warn: Primary pillar under pressure — Maintain operating margin near 7.8% to 8.0%: 3.8% vs 7.8%-8.0% target.
ABM aims for 4% to 5% revenue growth in 2026. Profit margin is expected near 8%. The company maintains EPS guidance of $3.85 to $4.15. Dividend stays steady at $0.29 per share.
Revenue growth has been weak recently with some quarters showing declines. EPS performance is mixed and guidance was cut recently. Management has shown volatility, which may hurt execution.
The price is about 39% below our fair value near $73. Analysts expect about 4% revenue growth, which aligns with management targets. Our view is cautious given recent guidance cuts and mixed execution.
Breaks if: Dividend per share falls below $0.29
ABM has declared a quarterly dividend of $0.29 per share, consistent with its capital allocation strategy.
Newly stated in 2026-Q1. Dividend per share was $0.29 in 2026-Q1, consistent with the company's capital allocation strategy. This newly stated priority aligns with maintaining shareholder returns through dividends.
“The Board of Directors declared a quarterly dividend of $0.29 per share.”
Breaks if: EPS guidance falls below $3.85 for FY26
ABM reaffirms its fiscal 2026 EPS guidance range of $3.85 to $4.15.
Stated in 3 of last 3 quarters. Diluted EPS was $0.64 in 2026-Q1, which is below the annual guidance range of $3.85 to $4.15. The recurring reaffirmation of EPS guidance suggests a focus on maintaining this target, but current performance indicates limited progress.
“The Company is reaffirming its fiscal 2026 outlook with adjusted EPS expected to be in the range of $3.85 to $4.15.”
“Adjusted EPS is expected to be in the range of $3.85 to $4.15.”
“We expect adjusted EPS in fiscal 2026 to be in the range of $3.85 to $4.15.”
Breaks if: Operating margin falls below 7.5% in FY26 Q4
Breaks if: YoY revenue growth falls below 4% in FY26
ABM aims for total revenue growth toward the top end of the 4% to 5% range for fiscal 2026.
Stated in 3 of last 3 quarters. Revenue was $2,243.5M in 2026-Q1, down from $2,295.3M in 2025-Q4, indicating a decline. Despite the recurring focus on achieving 4% to 5% growth, the trajectory shows limited progress so far.
“The Company now expects organic revenue growth toward the top end of the 3% to 4% range and total revenue growth toward the top end of the 4% to 5% range.”
“The Company continues to expect organic revenue growth of 3% to 4% and total revenue growth of 4% to 5%.”
“The WGNSTAR acquisition is anticipated to contribute an additional point of growth, bringing total expected revenue growth for 2026 to approximately 4% to 5%.”
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on steady revenue growth and dividend maintenance. The current thesis state is mixed, as management has reaffirmed growth and earnings targets despite recent performance challenges.
The market appears to price in a cheap valuation compared to peers, with expectations that are somewhat lower than what management has guided. The fragility in earnings quality suggests that investors are cautious about future performance.
Fundamentals may struggle to show significant improvement in the near term, given the mixed results and recent earnings misses. Management's focus on achieving revenue growth and maintaining EPS guidance indicates a commitment to improving performance, but recent results have not yet reflected this.
The long-term thesis hinges on the performance of sector bellwethers like CTAS, CPRT, and ROL, which could impact ABM's momentum. Additionally, any changes in guidance during upcoming earnings calls could significantly affect investor sentiment.
Over the next 1 to 3 years, ABM's outlook remains cautious due to mixed fundamentals and sector headwinds. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.